Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

NASDAQ Climbs Over 2% and Goes Positive for the Week

Published 09/25/2020, 09:15 PM
Updated 07/09/2023, 06:31 AM

New Zacks Feature: ASK ALEXA

Now call out a stock name or ticker. Alexa will give you its latest Zacks Rank and price. Also hear daily additions to and deletions from the services you follow. For easy directions on starting Zacks on Alexa, click here >>


Even after all the concerns lately about tech coming under pressure and losing its status as a market leader; the NASDAQ still managed to break its weekly losing streak on Friday with one of its best sessions of this difficult month.

The index jumped 2.26% (or about 241 points) today to 10,913.56. The result was its second best performance of September (Sept 9 was up 2.7%) and marked the end of its three-week losing skid.

The NASDAQ was higher by 1.1% this week! Though it’s down by well over 7% for the month thus far.

As you would expect, the FAANGs did very well with Apple (NASDAQ:AAPL) surging 3.75%. The rest of this group advanced more than 2% each, except for Alphabet (NASDAQ:GOOGL) (GOOG, +1.17%).

The other major indices weren’t just wasting time on Friday. They joined in on the fun as well, but it wasn’t enough to salvage the week.

The S&P rose 1.6% to 3298.46 and the Dow jumped 1.34% (or about 358 points) to 27,173.96. However, the losses were 0.6% and 1.8%, respectively, for the five days.

Therefore, the S&P and Dow now have four straight weeks of losses as we reach the homestretch of our first losing month since this pandemic stuff really got started back in March.

What can you say about this week... or this month? The market is anxious about several uncertainties, including rising coronavirus cases overseas, the lack of more help from Washington and the upcoming election.

As a result, volatility is back in a big way with tech taking it on the chin. There’s probably not going to be a lot of clarification on these issues in the near term, though it should be noted that House Democrats have suggested a $2.4 trillion stimulus plan. And who knows when the next bit of positive vaccine news will hit the market?

For now though, this solid end to the week should have investors breathing a bit easier heading into the weekend. And they should be ecstatic that September will mercifully come to an end next Wednesday.

Today's Portfolio Highlights:


Healthcare Innovators: This portfolio had the only stock in the ZU universe on Friday with a double-digit gain. Axcella Health (NASDAQ:AXLA) jumped 14.3% to easily become the top performer of the session. This emerging pharma company with a focus on liver diseases was added in late June. This service had another name in the Top 5 as Moderna (NASDAQ:MRNA) rose 6.6%.

Options Trader: "Stocks soared on Friday, although the Dow and the S&P both closed lower for the week (for the fourth week in a row), even though for a moment it looked like the S&P was going to turn positive. But the Nasdaq did, and they closed up for the week by more than 1%.

"The markets had been diligently tracing out a bottom earlier in the week, and it culminated in an explosive rally.

"The next upside targets for the S&P and the Nasdaq are as follows: with the S&P closing at 3,298.56, their 50-day moving average is overhead at 3,350.93. And just above that, there's a gap left on the chart at 3,384.45. Those are 1.59% and 2.61% away. Those are the near-term upside targets.

"For the Nasdaq: after closing at 10,913.56, their 50-day moving average is overhead at 11,024.92, while they also have a gap just above that at 11,046.43, which represents upside targets of 1.02% and 1.22% respectively.

"A solid close above the 50-day and the respective gaps would firm up the technical picture.

"In the meantime, everybody will be watching to see if the markets can build upon recent gains. Given the positive economic data, coupled with expectations for unprecedented growth for the remainder of the year, the foundation is in place for that to happen."
-- Kevin Matras

Have a Great Weekend!
Jim Giaquinto

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Recommendations from Zacks' Private Portfolios:

Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>


Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.